Dr. Barry Dworkin

Study shows that post MI use of polypill combination of ASA, ACE-inhibitor, and statin as opposed to individual pill forms improved secondary prevention outcomes due to better adherence to treatment.

Medical Mythbusting Commentary for August 29, 2022

Source:

Combination ‘polypill’ lowers the risk of major cardiovascular events, study finds

Reference:
Polypill Strategy in Secondary Cardiovascular Prevention

Related posts:

  1. Medications seem to work as well as stents for people with stable heart disease
  2. The decision to use cholesterol-lowering statins requires full cardiovascular risk assessment
  3. Observational study linking NSAIDs and increased heart attack risk has design flaws
  4. Blood pressure pills taken at night are more efficacious according to study.